Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor

Journal of Experimental Medicine

Volumn 193, Issue 9, 2001, Pages 1059-1065

  Farzan, Michael ^a   Schnitzler, Christine E ^b   Vasilieva, Natalya ^b   Leung, Doris ^b   Kuhn, Jens ^a   Gerard, Craig ^b   Gerard, Norma P ^b   Choe, Hyeryun ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

C5a; C5aR; CD88; Chemotactic receptors; Tyrosine sulfation

Indexed keywords

ANAPHYLATOXIN; CALCIUM; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; TYROSINE;

ARTICLE; CALCIUM MOBILIZATION; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN PROCESSING; RECEPTOR BINDING; SULFATION;

AMINO ACID SEQUENCE; ANTIGENS, CD; BINDING SITES; CALCIUM; CELL LINE, TRANSFORMED; COMPLEMENT C5A; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; SULFATES; TYROSINE;

EID: 0035821247     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.193.9.1059     Document Type: Article

References (28)

1. Gerard, C., and N.P. Gerard. 1994. C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12:775-808.
2. Wetsal, R.A., J. Kildsgaard, and D.L. Haviland. 2000. Complement anaphylatoxins (C3a, C4a, C5a) and their receptors (C3aR, C5aR/CD88) as therapeutic targets in inflammation. In Therapeutic Interventions in the Complement System. J.D. Lambris and V.M. Holers, editors. Humana Press, Totowa, NJ. 113-153.
3. Farzan, M., T. Mirzabekov, P. Kolchinsky, R. Wyatt, M. Cayabyab, N.P. Gerard, C. Gerard, J. Sodroski, and H. Choe. 1999. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell. 96:667-676.
4. Mery, L., and F. Boulay 1994. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding. J. Biol. Chem. 269:3457-3463.
5. Oppermann, M., U. Raedt, T. Hebell, B. Schmidt, B. Zimmermann, and O. Gotze. 1993. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain. J. Immunol. 151:3785-3794.
6. DeMartino, J.A., G. Van Riper, S.J. Siciliano, C.J. Molineaux, Z.D. Konteatis, H. Rosen, and M.S. Springer. 1994. The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs. J. Biol. Chem. 269:14446-14450.
7. Kawai, M., D.A. Quincy, B. Lane, K.W. Mollison, J.R. Luly, and G.W. Carter. 1991. Identification and synthesis of a receptor binding site of human anaphylatoxin C5a. J. Med. Chem. 34:2068-2071.
8. Bubeck, P., J. Grotzinger, M. Winkler, J. Kohl, A. Wollmer, A. Klos, and W. Bautsch. 1994. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor. Eur. J. Biochem. 219:897-904.
9. Mollison, K.W., W. Mandecki, E.R. Zuiderweg, L. Fayer, T.A. Fey, R.A. Krause, R.G. Conway, L. Miller, R.P. Edalji, M.A. Shallcross, et al. 1989. Identification of receptor-binding residues in the inflammatory complement protein C5a site-directed mutagenesis. Prof. Natl. Acad. Sci. USA. 86: 292-296.
10. Siciliano, S.J., T.E. Rollins, J. DeMartino, Z. Konteatis, L. Malkowitz, G. Van Riper, S. Bondy, H. Rosen, and M.S. Springer. 1994. Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors. Proc. Natl. Acad. Sci. USA. 91:1214-1218.
11. Crass, T., R.S. Ames, H.M. Sarau, M.A. Tornetta, J.J. Foley, J. Kohl, A. Klos, and W. Bautsch. 1999. Chimeric receptors of the human C3a receptor and C5a receptor (CD88). J. Biol. Chem. 274:8367-8370.
12. Chen, Z., X. Zhang, N.C. Gonnella, T.C. Pellas, W.C. Boyar, and F. Ni 1998. Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin. J. Biol. Chem. 273: 10411-10419.
13. Farzan, M., N. Vasilieva, C.E. Schnitzler, S. Chung, J. Robinson, N.P. Gerard, C. Gerard, H. Choe, and J. Sodroski. 2000. A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry. J. Biol. Chem. 275:33516-33521.
14. Gerard, N.P., and C. Gerard. 1991. The chemotactic receptor for human C5a anaphylatoxin. Nature. 349:614-617.
15. Werfel T., J. Zwirner, M. Oppermann, A. Sieber, G. Begemann, W. Drommer, A. Kapp, and O. Gotze. 1996. CD88 antibodies specifically bind to C5aR on dermal CD1171 and CD141 cells and react with a desmosomal antigen in human skin. J. Immunol. 157:1729-1735.
16. Amatruda, T.T., N.P. Gerard, C. Gerard, and M.I. Simon. 1993. Specific interaction of the chemoattractant factor receptors with G-proteins. J. Biol. Chem. 268:10139-10144.
17. Farzan, M., H. Choe, K.A. Martin, Y. Sun, M. Sidelko, C.R. Mackay, N.P. Gerard, J. Sodroski, and C. Gerard. 1997. HIV-1 entry and macrophage inflammatory protein-1b-mediated signaling are independent functions of the chemokine receptor CCR5. J. Biol. Chem. 272:6854-6857.
18. Huttner, W.B. 1988. Tyrosine sulfation and the secretory pathway. Annu. Rev. Physiol. 50:363-376.
19. Rosenquist, G.L., and H.B. Nicholas. 1993. Analysis of sequence requirements for protein tyrosine sulfation. Protein Sci. 2:215-222.
20. Bundgaard, J.R., J. Vuust, and J.F. Rehfeld. 1997. New consensus features for tyrosine O-sulfation determined by mutational analysis. J. Biol. Chem. 272:21700-21705.
21. Ouyang, Y.B. and K.L. Moore. 1998. Molecular cloning and expression of human and mouse tyrosylprotein sulfotransferase-2 and a tyrosylprotein sulfotransferase homologue in Caenorhabditis elegans. J. Biol. Chem. 273:24770-24774.
22. Beisswanger, R., D. Corbeil, C. Vannier, C. Thiele, U. Dohrmann, R. Kellner, K. Ashman, C. Niehrs, and W.B. Huttner. 1998. Existence of distinct tyrosylprotein sulfotransferase genes: molecular characterization of tyrosylprotein sulfotransferase-2. Proc. Natl. Acad. Sci. USA. 95:11134-11139.
23. Schwyzer, R. 1977. ACTH: a short introductory review. Ann. NY Acad. Sci. 297:3-26.
24. Kolakowski, L.F., B. Lu, C. Gerard, and N. P. Gerard. 1995. Probing the "message: address" sites for chemoattractant binding to the C5a receptor. J. Biol. Chem. 270:18077-18082.
25. Cormier, E.G., M. Persuh, D.A. Thompson, S.W. Lin, T.P. Sakmar, W.C. Olson, and T. Dragic. 2000. Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA. 97:5762-5767.
26. Toth, M.J., L. Huwyler, W.C. Boyar, A.F. Braunwalder, D. Yarwood, J. Hadala, W.O. Haston, M.A. Sills, B. Seligmann, and N. Galakatos. 1994. The pharmacophore of the human C5a anaphylatoxin. Protein Sci. 3:1159-1168.
27. Johnson, R.J., and D.E. Chenoweth. 1985. Structure and function of human C5a anaphylatoxin. Selective modification of tyrosine 23 alters biological activity but not antigenicity. J. Biol. Chem. 260:10339-10345.
28. Preobrazhensky, A.A., S. Dragan, T. Kawano, M.A. Gavrilin, I.V. Gulina, L. Chakravarty, and P.E. Kolattukudy. 2000. Monocyte chemotactic protein-1 receptor CCR2B is a glycoprotein that has tyrosine sulfation in a conserved extracellular N-terminal region. J. Immunol. 165:5295-5303.